Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gaucher disease: variability in phenotype among siblings.

D Amato1, T Stachiw, J T R Clarke

  • 1University of Toronto Faculty of Medicine and Mount Sinai Hospital, Toronto, Ontario, Canada. damato@mtsinai.on.ca

Journal of Inherited Metabolic Disease
|January 27, 2005
PubMed
Summary

Sibling studies reveal that genetic factors, not just GBA gene mutations, influence Gaucher disease severity. Environmental factors may also play a role in disease presentation and enzyme replacement therapy (ERT) initiation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The GBA p.Trp378Gly mutation is a probable French-Canadian founder mutation causing Gaucher disease and synucleinopathies.

Clinical genetics·2018
Same author

Thrombopoietin levels in Quebec platelet disorder-Implications for the mechanism of thrombocytopenia.

International journal of laboratory hematology·2018
Same author

Vaccinations are not associated with inhibitor development in boys with severe haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

EFhd2/Swiprosin-1 is a common genetic determinator for sensation-seeking/low anxiety and alcohol addiction.

Molecular psychiatry·2017
Same author

Severe bleeding diatheses in an elderly patient with combined type autoantibody against factor XIII A subunit; novel approach to the diagnosis and classification of anti-factor XIII antibodies.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3).

Journal of the European Academy of Dermatology and Venereology : JEADV·2017

Area of Science:

  • Genetics
  • Molecular Biology
  • Medical Research

Background:

  • Gaucher disease is caused by GBA gene mutations, but genotype-phenotype correlation is often poor.
  • Previous studies on genotype-phenotype correlation primarily involved unrelated individuals.
  • Sibling studies offer a unique perspective due to closer genetic relatedness.

Purpose of the Study:

  • To investigate genotype-phenotype correlation in Gaucher disease within sibling groups.
  • To examine the concordance of disease severity and enzyme replacement therapy (ERT) initiation among siblings.
  • To identify potential factors influencing variability in Gaucher disease presentation.

Main Methods:

  • Studied 24 Canadian sibling groups (mostly pairs) with type I Gaucher disease.

Related Experiment Videos

  • Used age of ERT initiation as a surrogate for disease severity, given uniform ERT guidelines.
  • Assessed clinical features and ERT status for concordance within sibling pairs.

    • Main Results:

    • 14 out of 24 sibling families showed concordance in ERT status and disease severity.
    • 10 out of 24 sibling families exhibited discordance in ERT status and clinical features.
    • Discordance suggests factors beyond GBA mutations influence Gaucher disease phenotype.

    Conclusions:

    • Sibling studies highlight the influence of genetic and environmental factors on Gaucher disease severity.
    • Variability in disease presentation may be attributed to micro-environmental factors at cellular or chromosomal levels.
    • Further research is needed to elucidate the complex interplay of factors determining Gaucher disease phenotype.